What is the Avanos Medical Inc. stock price forecast?

Avanos Medical Inc. is currently trading at $24.63. View real-time AI analysis on Alpha Lenz.

What is Avanos Medical Inc. insider trading activity?

View the latest insider trading data for Avanos Medical Inc. on Alpha Lenz.

What is Avanos Medical Inc.'s P/E ratio?

Avanos Medical Inc.'s P/E ratio is -2.9.

Avanos Medical Inc.

NYSE · AVNS

$24.63

Ask about Avanos Medical Inc.'s future dividend policy...

Alpha Chat Insight

“Avanos Medical Inc. trades at a P/E of -2.9 (undervalued) with modest ROE of -38.0%.”

Ask for details →

Company Overview

Avanos Medical Inc. is a healthcare company specializing in the development and production of medical devices designed to improve patient outcomes and reduce procedural costs. Primarily focusing on chronic care and pain management solutions, Avanos Medical offers a diverse range of products, including enteral feeding systems, respiratory therapy equipment, and advanced pain management technologies. The company's products are utilized in various healthcare settings such as hospitals, home care environments, and outpatient facilities. With its commitment to innovative healthcare solutions, Avanos Medical plays a crucial role in enhancing patient care quality and operational efficiency in the medical sector. By continually evolving its product offerings, Avanos seeks to address the growing demands and challenges faced by healthcare providers worldwide.

CEOMr. David C. Pacitti M.B.A.

Websitehttps://avanos.com

SectorHealthcare

IndustryMedical Devices

Employees2,227

Company Statistics

FY 2024

Profile

$1.13BMarket Cap

$687.80MRevenue

0.00Shares Out

2,227Employees

Margins

55.44%Gross

13.25%EBITDA

5.89%Operating

-58.64%Pre-Tax

-57.01%Net

Valuation

-2.89P/E

1.37P/B

1.65EV/Sales

13.12EV/EBITDA

13.67P/FCF

Growth (CAGR)

5.42%Rev 3Yr

-0.28%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-27.55%ROA

-37.98%ROE

-27.48%ROIC

Financial Health

$107.70MCash & Cash Equivalents

$218.00MNet Debt

39.31%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Avanos Medical Inc. trades at a P/E of -2.9 (undervalued) with modest ROE of -38.0%.”

Ask for details →

Frequently Asked Questions

Avanos Medical Inc. (ticker: AVNS) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 2,227 employees. Market cap is $1.1B.

The current price is $24.63 with a P/E ratio of -2.89x and P/B of 1.37x.

ROE is -37.98% and operating margin is 5.89%. Annual revenue is $688M.